283 related articles for article (PubMed ID: 34445128)
21. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
[TBL] [Abstract][Full Text] [Related]
22. Identification of therapeutic targets for glioblastoma by network analysis.
Friedmann-Morvinski D; Bhargava V; Gupta S; Verma IM; Subramaniam S
Oncogene; 2016 Feb; 35(5):608-20. PubMed ID: 25961929
[TBL] [Abstract][Full Text] [Related]
23. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt.
El-Sehemy A; Selvadurai H; Ortin-Martinez A; Pokrajac N; Mamatjan Y; Tachibana N; Rowland K; Lee L; Park N; Aldape K; Dirks P; Wallace VA
J Clin Invest; 2020 Jun; 130(6):3069-3086. PubMed ID: 32182224
[TBL] [Abstract][Full Text] [Related]
24. FERMT3 contributes to glioblastoma cell proliferation and chemoresistance to temozolomide through integrin mediated Wnt signaling.
Lu C; Cui C; Liu B; Zou S; Song H; Tian H; Zhao J; Li Y
Neurosci Lett; 2017 Sep; 657():77-83. PubMed ID: 28778805
[TBL] [Abstract][Full Text] [Related]
25. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
[TBL] [Abstract][Full Text] [Related]
26. R132H mutation in IDH1 gene reduces proliferation, cell survival and invasion of human glioma by downregulating Wnt/β-catenin signaling.
Cui D; Ren J; Shi J; Feng L; Wang K; Zeng T; Jin Y; Gao L
Int J Biochem Cell Biol; 2016 Apr; 73():72-81. PubMed ID: 26860959
[TBL] [Abstract][Full Text] [Related]
27. MSX1 inhibits cell migration and invasion through regulating the Wnt/β-catenin pathway in glioblastoma.
Tao H; Guo L; Chen L; Qiao G; Meng X; Xu B; Ye W
Tumour Biol; 2016 Jan; 37(1):1097-104. PubMed ID: 26271668
[TBL] [Abstract][Full Text] [Related]
28. HIF-1α/Wnt signaling-dependent control of gene transcription regulates neuronal differentiation of glioblastoma stem cells.
Boso D; Rampazzo E; Zanon C; Bresolin S; Maule F; Porcù E; Cani A; Della Puppa A; Trentin L; Basso G; Persano L
Theranostics; 2019; 9(17):4860-4877. PubMed ID: 31410187
[TBL] [Abstract][Full Text] [Related]
29. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
30. Wnt pathway markers in molecular subgroups of glioblastoma.
Tompa M; Nagy A; Komoly S; Kalman B
Brain Res; 2019 Sep; 1718():114-125. PubMed ID: 31075260
[TBL] [Abstract][Full Text] [Related]
31. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
[TBL] [Abstract][Full Text] [Related]
32. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
[TBL] [Abstract][Full Text] [Related]
33. Wnt/β-catenin pathway involvement in ionizing radiation-induced invasion of U87 glioblastoma cells.
Dong Z; Zhou L; Han N; Zhang M; Lyu X
Strahlenther Onkol; 2015 Aug; 191(8):672-80. PubMed ID: 26072169
[TBL] [Abstract][Full Text] [Related]
34. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
[TBL] [Abstract][Full Text] [Related]
35. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion.
Náger M; Santacana M; Bhardwaj D; Valls J; Ferrer I; Nogués P; Cantí C; Herreros J
Cell Cycle; 2015; 14(22):3644-55. PubMed ID: 26654598
[TBL] [Abstract][Full Text] [Related]
36. Norrin mediates opposing effects on tumor progression of glioblastoma stem cells.
Kassumeh S; Priglinger SG; Ohlmann A
J Clin Invest; 2020 Jun; 130(6):2814-2815. PubMed ID: 32391807
[TBL] [Abstract][Full Text] [Related]
37. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Bevacizumab-induced Epithelial-Mesenchymal Transition by BATF2 Overexpression Involves the Suppression of Wnt/β-Catenin Signaling in Glioblastoma Cells.
Huang W; Zhang C; Cui M; Niu J; Ding W
Anticancer Res; 2017 Aug; 37(8):4285-4294. PubMed ID: 28739720
[TBL] [Abstract][Full Text] [Related]
39. MiR-449b-5p inhibits human glioblastoma cell proliferation by inactivating WNT2B/Wnt/β-catenin signaling pathway.
Hou WZ; Chen XL; Qin LS; Xu ZJ; Liao GM; Chen D; Hu LJ; Mao ZM; -S Huang J; Yuan Q; Liao C; Yao QM
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5549-5557. PubMed ID: 32495889
[TBL] [Abstract][Full Text] [Related]
40. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]